Talis Biomedical Corp Litigation

Sep 9, 2025

Disbursement Approved

The court has approved the distribution of settlement funds to eligible class members. Investors with approved claims may receive payments from the settlement. If you have questions about your claim or payment, contact the claims administrator.

Mar 13, 2025

Final Approval of Settlement

The court has granted final approval of the settlement. Eligible investors who submit valid claims may receive a payment once the claims review and distribution process is completed.

Jan 17, 2025

Motion for Final Approval of Settlement

The parties have asked the court to grant final approval of the proposed settlement. The judge will consider whether the settlement should be approved after reviewing the settlement terms and any objections. If approved, eligible investors who submit valid claims may receive a payment after the claims review and distribution process is completed.

Nov 22, 2024

Proof of Claim Form

To receive your portion of the recovery (if you are eligible), you must submit this form to the claims administrator by the deadline indicated on the form itself. If you do not submit this form in time, you will not be entitled to compensation. If you have questions about how to complete the form, you should contact the claims administrator.

Nov 22, 2024

Notice of Pendency

Nov 22, 2024

Preliminary Approval of Settlement

The court has granted preliminary approval of a proposed settlement. This means the settlement can move forward for further consideration, but it has not yet received final approval. Potential class members will generally receive notice explaining the settlement, their rights, and any deadlines for submitting a claim, objecting to the settlement, or choosing not to participate.

Oct 1, 2024

Motion for Preliminary Approval of Settlement

The parties have asked the court to give preliminary approval to a proposed settlement. The judge will review the request and decide whether the settlement can move forward to the next stage. If approved, potential class members will generally receive information about the settlement and their rights, including any deadlines for taking action.

Feb 9, 2024

Class Certification Granted

The court has determined that a class action is the appropriate method to bring the claims by class members. Usually, when a class is certified, the judge will also affirm an individual or entity to represent the class and finalize a class definition (i.e.: who is represented in the lawsuit).

Oct 13, 2023

Motion for Class Certification

The plaintiffs have asked the court to approve the lawsuit to proceed as a class action on behalf of a group of investors. The judge will decide whether the case meets the requirements for class certification and which investors and claims may be included.

Apr 28, 2023

Motion to Dismiss Denied

The court has denied the defendants' request to dismiss the lawsuit. The case can now move forward to the next stage of litigation.

Feb 17, 2023

Motion to Dismiss

After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.

Jan 13, 2023

Second Amended Complaint

A new complaint has been filed on behalf of certain investors in Talis Biomedical Corp. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.

Dec 9, 2022

Motion to Dismiss Granted

The court has granted the defendants' request to dismiss the lawsuit. Depending on the court's decision, the plaintiffs may be allowed to file an updated complaint or pursue an appeal.

Aug 5, 2022

Motion to Dismiss

After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.

Jul 1, 2022

First Amended Complaint

A new complaint has been filed on behalf of certain investors in Talis Biomedical Corp. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.

Jun 3, 2022

Appointment of Lead Plaintiff

The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.

Feb 18, 2022

Additional Complaint

Another plaintiff has filed a complaint on behalf of investors in Talis Biomedical Corp. The allegations and class definitions are substantively the same.

Jan 7, 2022

First Filed Complaint

A securities fraud class action complaint has been filed on behalf of certain investors in Talis Biomedical Corp.